Psoriasis.
Boehncke WH, Schön MP.
Lancet. 2015 Sep 5;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7. Epub 2015 May 27.
Psoriasis Pathogenesis and Treatment.
Rendon A, Schäkel K.
Int J Mol Sci. 2019 Mar 23;20(6):1475. doi: 10.3390/ijms20061475.
Risk Factors for the Development of Psoriasis.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M.
Int J Mol Sci. 2019 Sep 5;20(18):4347. doi: 10.3390/ijms20184347.
Psoriasis.
Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN.
Lancet. 2021 Apr 3;397(10281):1301-1315. doi: 10.1016/S0140-6736(20)32549-6.
Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics.
Petit RG, Cano A, Ortiz A, Espina M, Prat J, Muñoz M, Severino P, Souto EB, García ML, Pujol M, Sánchez-López E.
Int J Mol Sci. 2021 May 7;22(9):4983. doi: 10.3390/ijms22094983.
Pathogenesis and clinical features of psoriasis.
Griffiths CE, Barker JN.
Lancet. 2007 Jul 21;370(9583):263-271. doi: 10.1016/S0140-6736(07)61128-3.
Psoriasis: epidemiology, clinical features, and quality of life.
Langley RG, Krueger GG, Griffiths CE.
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii18-23; discussion ii24-5. doi: 10.1136/ard.2004.033217.
Management of psoriasis as a systemic disease: what is the evidence?
Korman NJ.
Br J Dermatol. 2020 Apr;182(4):840-848. doi: 10.1111/bjd.18245. Epub 2019 Oct 15.
The skin in psoriasis: assessment and challenges.
Oji V, Luger TA.
Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S14-9. Epub 2015 Oct 15.
Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities.
Bronckers IM, Paller AS, van Geel MJ, van de Kerkhof PC, Seyger MM.
Paediatr Drugs. 2015 Oct;17(5):373-84. doi: 10.1007/s40272-015-0137-1.
